
Company Info
Year Established2019
Contacts
Heide Ford, PhDCo-Founder & Co-CSO
Company Description
Sieyax is developing novel small molecule cancer drugs to treat the most aggressive and devastating cancers.

Sieyax is developing novel small molecule cancer drugs to treat the most aggressive and devastating cancers.